Compare TLSA & SILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLSA | SILC |
|---|---|---|
| Founded | 2013 | 1987 |
| Country | United Kingdom | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 200.8M | 79.8M |
| IPO Year | 2000 | 1994 |
| Metric | TLSA | SILC |
|---|---|---|
| Price | $1.77 | $14.64 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 285.5K | 14.0K |
| Earning Date | 01-01-0001 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $59,509,000.00 |
| Revenue This Year | N/A | $6.48 |
| Revenue Next Year | N/A | $14.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $12.44 |
| 52 Week High | $2.60 | $19.37 |
| Indicator | TLSA | SILC |
|---|---|---|
| Relative Strength Index (RSI) | 50.49 | 44.41 |
| Support Level | $1.62 | $14.15 |
| Resistance Level | $1.82 | $14.88 |
| Average True Range (ATR) | 0.14 | 0.51 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 60.84 | 26.54 |
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, FPGA-Based Cards, x86 Open Appliances, Bypass Switches, and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.